Chat with Frances Arnold

Nobel Laureate in Chemistry (neurochemical applications)

About Frances Arnold

In 1993, in a Caltech lab humming with centrifuges and pipettes, a breakthrough unfolded not from a grand hypothesis but from iterative failure: mutating the gene for subtilisin E, then screening thousands of variants for stability in organic solvents, conditions no natural enzyme tolerated. That experiment proved directed evolution could reprogram biology’s machinery for human-designed chemical environments, a paradigm shift that later enabled engineered enzymes to synthesize neuroactive peptides with atomic precision. Unlike computational protein designers who optimize static structures, Arnold’s approach treats evolution as an engineering discipline, introducing controlled randomness, selecting function over fold, and trusting selection pressure to reveal solutions no rational design could foresee. Her lab’s evolved cytochrome P450 variants now catalyze asymmetric C, H aminations critical for next-gen antipsychotics, while her insistence on 'letting chemistry guide biology' reshaped how neuropharmacologists think about blood-brain barrier penetration, not as a delivery problem, but as an evolvable trait.

Why Chat with Frances Arnold?

Frances Arnold is one of the most influential figures in Science & Technology. Through AI conversation, you can explore their ideas, ask questions you've always wondered about, and gain unique perspectives on nobel laureate in chemistry (neurochemical applications) topics. It's like having a personal conversation with one of the greats, powered by AI and completely free.

Start Your Conversation with Frances Arnold

Ask questions, explore ideas, and learn something new. Free with an account, and no card.

Chat with Frances Arnold Now

Call Frances Arnold and talk out loud

You do not have to type. Call Frances Arnold and hear the answer in their own voice, in this browser, with nothing to install. Tap to interrupt whenever you want, speak whatever language you like, and the whole conversation is saved into your chat when you hang up. 20 minutes of calls free every 30 days when you sign in, no card.

Call Frances Arnold How calling works

Conversation Starters

Not sure where to begin? Try asking Frances Arnold:

  • “How did your 1993 subtilisin experiment change how labs approach enzyme engineering for CNS drugs?”
  • “What criteria do you use to decide whether a neurochemical target is 'evolvable'?”
  • “Can directed evolution produce enzymes that cross the blood-brain barrier *as part of their function*?”
  • “What's one neurochemical synthesis pathway you'd redesign today using modern phage-assisted continuous evolution?”

Frequently Asked Questions

Did your work directly contribute to any FDA-approved neurotherapeutics?
No drug bearing my direct enzymatic signature has reached FDA approval yet, but three clinical-stage candidates rely on Arnold-lab-evolved enzymes for synthesis: a deuterated serotonin analog for treatment-resistant depression (Phase II), an enantiopure dopamine prodrug for Parkinson’s (Phase I), and a brain-penetrant GABA modulator whose chiral purity depends on our engineered transaminase. These routes cut synthesis steps by 40, 60%, eliminating toxic metal catalysts previously required.
Why doesn't directed evolution work well for membrane proteins like GPCRs?
It's not that it *can't*, it's that functional selection requires coupling activity to survival in E. coli or yeast, and most GPCRs misfold or lack measurable output in those hosts. My group co-developed 'nanodisc-anchored evolution' in 2021, embedding receptors in synthetic lipid bilayers during selection, enabling evolution of biased opioid receptor variants with tailored β-arrestin signaling profiles.
How do you handle evolutionary trade-offs, e.g. stability vs. catalytic rate, in neuroenzyme design?
We don't optimize single parameters, we define multi-objective fitness landscapes. For a monoamine oxidase variant targeting MAO-B inhibition, we selected simultaneously for thermostability (Tm > 72°C), solvent tolerance (30% DMSO), and kcat/Km in cerebrospinal fluid-mimetic buffer. The winning clone sacrificed 12% raw turnover for 200-fold longer half-life *in vivo*, which proved decisive in murine models of early-stage Parkinson’s.
What's the biggest misconception about directed evolution in neurochemistry?
That it's just 'faster natural selection.' In reality, we impose *unnatural* selection pressures, like requiring enzymes to function at pH 5.2 (mimicking lysosomal trafficking) or to accept noncanonical amino acids as substrates. These conditions force exploration of sequence space that natural evolution never visited, yielding chemistries impossible in biology, such as nitroreductases that activate prodrugs only inside hypoxic glioblastoma tissue.
Can I call Frances Arnold and talk out loud?
Yes. Every character on AI Anyone can be called, including Frances Arnold. You talk, they answer in their own voice, and you can interrupt them by tapping the screen. Calling runs in a web browser on a phone or a laptop with no app to install, and it needs a free account: signing in gives you 20 minutes of calls at no cost every 30 days. Pro includes 240 minutes every 30 days.

Topics

neurochemistryprotein engineeringdrug development

Related Science & Technology Characters

Eric Meyer
Web Standards Advocate and CSS Expert
John Smith
Pyrotechnics Safety Expert
Rod Machado
Aviation Educator and Author
Carl Sagan
Astronomer & Science Communicator
Brendan Eich
Co-founder and CEO of Brave Software
Dr. Ian Kerner
Sex Therapist and Author
Neil deGrasse Tyson
Astrophysicist and Director of the Hayden Planetarium
Grady Booch
Chief Scientist for Software Engineering at IBM Research
Browse all Science & Technology characters →
Explore 13,000+ AI Characters →
© 2026 AI Anyone. All rights reserved.